Cited by 6Attention Deficit Hyperactivity DisorderPharmaceutical studies and practicesNeurotransmitter Receptor Influence on Behavior

Gender Effects in the Efficacy of Racemic Amphetamine Sulfate in Children with Attention-Deficit/Hyperactivity Disorder

Open access
Childress, Ann C., Newcorn, Jeffrey H., Cutler, Andrew J.·2019·Advances in Therapy

Abstract

INTRODUCTION: A laboratory classroom study in children aged 6-12 years with attention-deficit/hyperactivity disorder (ADHD) found that racemic amphetamine sulfate (RA-AMPH) significantly improved performance versus placebo from 45 min through 10 h post-dose (NCT01986062). A secondary analysis assessed gender as a potential moderator of response to treatment comparing the ADHD Rating Scale-IV (ADHD-RS-IV) and Swanson, Kotkin, Agler, M-Flynn and Pelham (SKAMP) rating scales. METHODS: After 8 weeks of open-label RA-AMPH dose optimization using improvement in ADHD-RS-IV symptoms as a guide, 97 subjects (38 females and 59 males) were randomized to the sequence of 2 weeks of double-blind treatment with the optimized dose of RA-AMPH followed by placebo or vice versa during a laboratory classroom day. Efficacy measures included the SKAMP and the Permanent Product Measure of Performance (PERMP). The average difference for RA-AMPH versus placebo was estimated using least-square (LS) means. Treatment interaction by gender was analyzed using a cross-sectional fixed-effects model. RESULTS: ADHD-RS-IV scores were comparable for males and females at study entry and at the end of open-label treatment. During double-blind treatment, LS mean scores significantly improved for both genders versus placebo on the SKAMP scale and the PERMP (average p < 0.0001 for all post-dose time points). Beginning at baseline, males had significantly higher (worse) SKAMP scores than females but not worse ADHD-RS-IV or PERMP scores. CONCLUSION: Both genders responded well to treatment with RA-AMPH, with comparable onset and duration of effect. The ADHD-RS-IV and SKAMP scales both measure changes in attention and hyperactive-impulsive behavior, but the SKAMP scale also measures associated disruptive behaviors, such as frustration, lying, and interpersonal conflict, that are more characteristic of oppositional and conduct disorders and more prevalent in boys with ADHD. Therefore, the SKAMP may be more sensitive for measuring the range of symptoms of boys with ADHD than the ADHD-RS-IV. FUNDING: Arbor Pharmaceuticals, LLC.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s12325-019-00942-5

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Age and sex influence the effectiveness of medication treatment.

    “At the same time, the factors of age and sex also complicate individual medication selection as they influence the effectiveness of medication treatment (Childress, Newcorn, & Cutler, 2019; Dafny & Yang, 2006; Wigal, Kollins, Childress, & Adeyi, 2010).”

    From Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis (2024) · cites this paper as Childress, Newcorn, & Cutler, 2019

    The Conclusion (page not provided) says boys and girls with ADHD responded equally well to racemic amphetamine sulfate, with comparable onset and duration of effect. The Results found no significant or consistent difference in effect size by gender, apart from isolated treatment-by-gender interactions at 2 hours. The paper does not establish that age influences treatment effectiveness. (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [40]Conners CK Conners 3rd edition manual 2008 North Tonawanda Multi-Health Systems

Cited by

Sorted by citations

Authors
Childress, A. C., Newcorn, J. H., & Cutler, A. J.
Affiliations
  • Center for Psychiatry and Behavioral Medicine (US)
  • Meridien Research (US)
Corresponding author
Childress, Ann C.
Venue
Advances in Therapy
Published
2019-04-10
Volume
36
Issue
6
Pages
1370-1387
ISSN
  • 0741-238X (ISSN-L)
  • 1865-8652
OpenAlex
W2937281867
Cited by
6
References
34
Citations by year
2025: 1 · 2024: 4 · 2021: 1
FWCI
0.20
Type
journal article
Language
en
Open access
Locations
  • Advances in Therapy (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
Funders
Arbor Pharmaceuticals, LLC.
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmaceutical studies and practices
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
attention deficit hyperactivity disorder, gender differences, treatment response, ADHD Rating Scale-IV, stimulant medication, disruptive behavior
MeSH terms
Amphetamine, Central Nervous System Stimulants, Attention Deficit Disorder with Hyperactivity, Child, Cross-Sectional Studies, Delayed-Action Preparations, Double-Blind Method, Female, Humans, Male, Psychiatric Status Rating Scales, Sex Factors, United States, Treatment Outcome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review